Learn how nonalcoholic fatty liver disease develops, its warning signs, and the steps to help safeguard the liver.

Where multiple sensitivity and specificity values are reported, the values providing the highest Youden Index are given (i.e., highest sum of sensitivity and specificity minus one). ALT: Alanine ...

Researchers predict a steady increase in fatty liver disease in the U.S. population, but there's not a lot of treatment options available.

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. World revenue for the Liver Fibrosis ...

Regular junk food consumption, laden with unhealthy fats and sugars, significantly threatens liver health, leading to ...

Data from patients across 3 different randomized controlled trials showed improvements in both adiponectin and PRO-C3, primary end points in the trials.

Nonalcoholic fatty liver disease is the most common liver disease in America. If you have any of these fatty liver symptoms see your doctor right away. The post 9 Fatty Liver Symptoms You Need to ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

Rosacea, a chronic skin condition causing redness and visible blood vessels on the face, has been associated with liver ...

NASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects millions of people and which, for several years, has been billed as pharma's next big growth area. Although, so far efforts ...

Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic ...

Revenue forecasts to 2035 for Liver Fibrosis & NASH/MASH Drugs Market 2025 to 2035, with forecasts for Type and Indication, each forecast at a global and regional level - discover the industry's ...